Tołpa Torf Preparation (TTP) Induces Interferon and Tumor Necrosis Factor Production in Human Peripheral Blood Leukocytes
in-vitro Grade C 1993
Authors: Inglot, A.D., Zielińska-Jenczylik, J., Piasecki, E.
Journal: Archivum Immunologiae et Therapiae Experimentalis 41 (1) : 73-80
PubMed: PMID 7694559
Key Findings
- Tołpa Torf Preparation (TTP), a low-molecular-weight peat extract registered as an immunomodulating drug in Poland, was tested on human peripheral blood leukocyte cultures
- TTP induced dose-dependent interferon and tumor necrosis factor (TNF) production
- The optimal concentration for interferon and TNF response was 10-100 µg/ml
An ex-vivo human leukocyte study showing that Tołpa Torf Preparation (TTP) — the peat-derived immunomodulatory preparation registered in Poland — directly induces interferon and TNF production in human immune cells, within a defined dose window. This is primary human-cell evidence behind TTP’s registered immunomodulator status. Abstract-only sourcing; no full text was located.
Where this source is used on this site
Each page below cites this paper as evidence for a specific claim. The note shows what the page draws from it.
Substance Humic Acids
Primary human-cell evidence: TPP induced dose-dependent interferon and TNF production in human peripheral blood leukocytes, optimal at 10-100 µg/ml — direct source behind the ubner-2013 review claim
tppimmunomodulatoryinterferontnf-alphain-vitro